Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Acquisitions (2023)

Catheter Precision (VTAK) has disclosed Acquisitions for 1 consecutive years, with -$72.5 million as the latest value for Q4 2023.

  • Quarterly Acquisitions changed N/A to -$72.5 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$72.5 million through Sep 2024, down 199.98% year-over-year, with the annual reading at $15000.0 for FY2023, N/A changed from the prior year.
  • Acquisitions for Q4 2023 was -$72.5 million at Catheter Precision, down from $72.6 million in the prior quarter.
  • The five-year high for Acquisitions was $72.6 million in Q2 2023, with the low at -$72.5 million in Q4 2023.